CSIC Delegation in the Region of Valencia

CSIC Delegation in the Region of Valencia

Information
Calle Bailía, 1 (Plaza de la Virgen). 46003 - València

addictions, Alzheimer's, astrophysics, bioethics, climate change, cancer, natural sciences, climate, quantum computing, pollution, covid-19, embryonic development, diabetes, gene editing, education, energy, cardiovascular diseases, neurodegenerative diseases, rare diseases, ageing, epidemiology, STDs, physics, immunology, artificial intelligence, language, microbiology, nanoscience, neuroscience, new materials, chemistry, mental health, AIDS / HIV, sociology, supercomputing, transgenics
Contact
Isidoro García Cano
Head of Communication
isidoro.garcia@dicv.csic.es
+34 96 362 27 57
Sergio Villalba Lapeña
R+D+i Technician
g.prensa@dicv.csic.es
+34 96 362 27 57

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Director of the Institute of Neurosciences, a joint centre of the Miguel Hernández University of Elche (UMH) and the CSIC

Researcher at the Institute of Molecular and Cellular Biology of Plants (UPV-CSIC)

Researcher at the Climate, Atmosphere and Oceans Laboratory (Climatoc-Lab) at the Desertification Research Centre (CIDE, CSIC-UV-GVA)

Senior Scientist in Social Sciences at INGENIO (CSIC-UPV)

CIDEGENT Distinguished Researcher

Researcher, Instituto de Física Corpuscular 

Professor of the Department of Theoretical Physics & IFIC of the University of Valencia - CSIC

Coordinator of the CSIC Global Health Platform and researcher at the Instituto de Biomedicina de Valencia (IBV-CSIC)

CSIC Group Leader at the Institute of Neurosciences (CSIC-UMH)

Full CSIC scientist at the Institute of Biomedicine of Valencia (CSIC-CIBERNED)

Contents related to this centre
IPBES

Meeting in the city of Windoek (Namibia), the plenary of the IPBES - Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services - has ratified two new reports: the Nexus Assessment and the Transformative Change Assessment. Three of their authors explained the main findings and the changes they propose at a briefing organised by SMC Spain.

aridity

More than three-quarters of the earth's land surface experienced drier climates between 1990 and 2020 compared to the previous three decades, according to a new report by the United Nations Convention to Combat Desertification. Over the past 30 years, 40.6 percent of the global landmass, excluding Antarctica, is classified as drylands, three percentage points more than the previous three decades. The report, which is being presented at the COP16 on desertification being held in Riyadh, Saudi Arabia, also shows that 2.3 billion people were living in drylands in 2020, a population that could rise to 5 billion by 2100 under a worst-case climate change scenario.

rat

The seventh Annual Report of the COSCE Transparency Agreement, prepared by the European Animal Research Association, which analyses transparency in the use of animals for scientific experimentation in Spain in 2023, was presented today. According to the document, transparency is consolidated among the signatory institutions -168 in 2024- and all of them publish a statement on their websites on the use of animals. Public mention of the number and species used stands at 47%, compared to 38% the previous year.

EMA

Less than four months after the European Medicines Agency recommended in July not to grant marketing authorisation for Leqembi™ (lecanemab) for the treatment of Alzheimer's disease, the EMA's Committee for Medicinal Products for Human Use (CHMP) has reassessed the available evidence to conclude that the benefits outweigh the risks.

 

Nobel Medicina

The Karolinska Institute has awarded the Nobel Prize in Medicine or Physiology to Victor Ambros and Gary Ruvkun for the discovery of microRNAs, small RNA fragments that do not contain instructions for making proteins but instead participate in the regulation of gene expression. Their role is fundamental in processes such as cell differentiation, and their alteration can influence diseases like cancer.

Alzheimer

A family of more than 1,000 members with origins in Colombia has a mutation called "paisa" that leads to the development of Alzheimer's disease. In 2019, an added mutation in the apoE gene called "Christchurch" was described as conferring strong protection to an individual carrying two copies of it. Now, a study has found that 27 family members carry a single copy and that it is also associated with some degree of protection. According to the authors, who publish their findings in the journal NEJM, the discovery could be used to develop new treatments for the disease. 

Alzheimer

Genetic forms of Alzheimer's are considered to be those in which certain variants of a gene inevitably lead to the disease over time. Until now, only rare alterations in three genes were considered as such. A group of researchers led by the Hospital de Sant Pau in Barcelona has proposed a new, much more frequent form. After analysing data from more than three thousand donated brains and clinical data from more than ten thousand patients, they found that almost all people who carry two copies of the ApoE4 variant in the ApoE gene, which was previously only considered a risk factor, also end up developing the disease.They publish the results in the journal Nature Medicine.  

water

A "large fraction" of groundwater samples are contaminated by perfluoroalkyl and polyfluoroalkyl substances (PFASs) and would be considered unacceptable for drinking water, a study claims. The analysis, published by Nature Geoscience, brings together data from 273 studies of surface and groundwater samples from around the world since 2004. The exact proportion of samples exceeding the thresholds varies according to the standards considered. For example, 69% of groundwater samples with no known source of contamination exceed the Canadian threshold, but the figure is only 6% if the EU criterion for the sum of all PFASs is considered.

brain

The Science group of journals publishes several parts of a high-resolution atlas of human brain cells, the largest 'map' of its kind to date. It is a series of papers from an international mega-project, the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative - Cell Census Network (BICCN), launched in 2017 to study brain cell types and their functions in humans, non-human primates and rodents. The data "will now allow researchers to address fundamental scientific questions about the human brain and its genetic organisation," states the introduction to the journal's special issue.

mice

Early-life adversity, such as separation from the mother, can alter the neurological functioning of mice, causing some to experience panic and anxiety later in life. A study shows that these changes can be passed on for at least two generations and that inhalation of a drug, the diuretic amiloride, can reverse them. According to the authors, this treatment could be used in the future to alleviate panic disorders and related conditions in humans. The results are published in the journal Science Advances.